The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MAVERICC, a phase II study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC): Outcomes by tumor location and KRAS status.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Fa-Chyi Lee
No Relationships to Disclose
 
Linda Yau
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Han A. Koh
No Relationships to Disclose
 
James A. Knost
No Relationships to Disclose
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
Ivan Bosanac
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Christoph Mancao
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Aparna Parikh
Employment - Genentech
Stock and Other Ownership Interests - Genentech